Florida Senate - 2025 SB 876 By Senator Berman 26-01316-25 2025876__ 1 A bill to be entitled 2 An act relating to chimeric antigen receptor T-cell 3 therapy; creating ss. 627.64198, 627.6614, and 4 641.31078, F.S.; prohibiting health insurers and 5 health maintenance organizations issuing, delivering, 6 or renewing certain policies or contracts from 7 refusing to contract with or denying coverage for 8 certain providers of chimeric antigen receptor T-cell 9 therapy; providing an effective date. 10 11 Be It Enacted by the Legislature of the State of Florida: 12 13 Section 1. Section 627.64198, Florida Statutes, is created 14 to read: 15 627.64198 CAR-T therapy providers.—A health insurer 16 issuing, delivering, or renewing a health insurance policy in 17 this state on or after January 1, 2026, which provides coverage 18 for chimeric antigen receptor T-cell (CAR-T) therapy may not 19 refuse to contract with or deny coverage for the administration 20 of CAR-T therapy by any provider that qualifies as a certified 21 health care facility under the Food and Drug Administration 22 procedure for the CAR-T product license and that is included in 23 the policy’s provider network for any other service. 24 Section 2. Section 627.6614, Florida Statutes, is created 25 to read: 26 627.6614 CAR-T therapy providers.—A health insurer issuing, 27 delivering, or renewing a group health insurance policy in this 28 state on or after January 1, 2026, which provides coverage for 29 chimeric antigen receptor T-cell (CAR-T) therapy may not refuse 30 to contract with or deny coverage for the administration of CAR 31 T therapy by any provider that qualifies as a certified health 32 care facility under the Food and Drug Administration procedure 33 for the CAR-T product license and that is included in the 34 policy’s provider network for any other service. 35 Section 3. Section 641.31078, Florida Statutes, is created 36 to read: 37 641.31078 CAR-T therapy providers.—A health maintenance 38 organization issuing, delivering, or renewing a health 39 maintenance contract in this state on or after January 1, 2026, 40 which provides coverage for chimeric antigen receptor T-cell 41 (CAR-T) therapy may not refuse to contract with or deny coverage 42 for the administration of CAR-T therapy by any provider that 43 qualifies as a certified health care facility under the Food and 44 Drug Administration procedure for the CAR-T product license and 45 that is included in the policy’s provider network for any other 46 service. 47 Section 4. This act shall take effect January 1, 2026.